We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LX
1476
LexinFintech Holdings
LX
$241M
$1.83M ﹤0.01%
675,473
-204,666
-23% -$591K
OMF icon
1477
OneMain Financial
OMF
$7.19B
$1.83M ﹤0.01%
49,299
+47,999
+3,692% +$1.93M
PLTK icon
1478
Playtika
PLTK
$1.51B
$1.83M ﹤0.01%
+162,297
New +$1.63M
EPC icon
1479
Edgewell Personal Care
EPC
$1.3B
$1.82M ﹤0.01%
+42,913
New +$1.8M
DENN
1480
DELISTED
Denny's
DENN
$1.81M ﹤0.01%
161,908
+38,302
+31% +$445K
RNAC icon
1481
Cartesian Therapeutics
RNAC
$225M
$1.81M ﹤0.01%
43,292
-389
-0.9% -$18.3K
TNC icon
1482
Tennant Co
TNC
$1.5B
$1.8M ﹤0.01%
+26,267
New +$1.78M
RTO icon
1483
Rentokil
RTO
$14.5B
$1.8M ﹤0.01%
+49,228
New +$1.55M
PRVB
1484
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.8M ﹤0.01%
+74,500
New +$935K
TSM icon
1485
PUT
TSMC
TSM
$2.03T
$1.8M ﹤0.01%
19,300
+12,900
+202% +$1.16M
ANNX icon
1486
Annexon
ANNX
$814M
$1.79M ﹤0.01%
464,819
+435,963
+1,511% +$2.4M
STNE icon
1487
StoneCo
STNE
$2.71B
$1.79M ﹤0.01%
+187,291
New +$1.79M
HCNEW
1488
CALL
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$1.78M ﹤0.01%
174,995
CE icon
1489
Celanese
CE
$4.77B
$1.77M ﹤0.01%
+16,254
New +$1.88M
IGV icon
1490
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.3B
$1.77M ﹤0.01%
29,000
+28,000
+2,800% +$1.57M
TENB icon
1491
Tenable Holdings
TENB
$3.46B
$1.77M ﹤0.01%
+37,182
New +$1.58M
APCA.WS
1492
CALL
DELISTED
AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
APCA.WS
$1.77M ﹤0.01%
167,375
NUVA
1493
DELISTED
NuVasive, Inc.
NUVA
$1.77M ﹤0.01%
+42,738
New +$1.83M
APAM icon
1494
Artisan Partners
APAM
$2.9B
$1.76M ﹤0.01%
55,173
-77,213
-58% -$2.59M
GIII icon
1495
G-III Apparel Group
GIII
$1.55B
$1.76M ﹤0.01%
+113,151
New +$1.77M
GBBK
1496
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$1.74M ﹤0.01%
169,674
XME icon
1497
State Street SPDR S&P Metals & Mining ETF
XME
$3.9B
$1.74M ﹤0.01%
+32,800
New +$1.78M
HCA icon
1498
HCA Healthcare
HCA
$92.8B
$1.74M ﹤0.01%
6,611
-13,504
-67% -$3.43M
BAND
1499
Bandwidth Inc
BAND
$1.67B
$1.74M ﹤0.01%
+114,652
New +$2.31M
OSI.WS
1500
CALL
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$1.74M ﹤0.01%
174,997

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.